Strazzulla A, Cocuzza S, Pinzone MR, Postorino MC, Cosentino S, Serra A, Cacopardo B, Nunnari G, 2013. Mucosal leishmaniasis: an underestimated presentation of a neglected disease. BioMed Res Int 2013: 805108.
Daulatabad D, Singal A, Dhawan A, Pandhi D, Sharma S, 2015. Mucocutaneous leishmaniasis caused by Leishmania donovani infection in an Indian man. Int J Dermatol 54: 680–684.
Aliaga L, Cobo F, Mediavilla JD, Bravo J, Osuna A, Amador JM, Martin-Sanchez J, Cordero E, Navarro JM, 2003. Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients. Medicine (Baltimore) 82: 147–158.
Shirian S, Oryan A, Hatam GR, Daneshbod Y, 2012. Mixed mucosal leishmaniasis infection caused by Leishmania tropica and Leishmania major. J Clin Microbiol 50: 3805–3808.
Shirian S, Oryan A, Hatam GR, Daneshbod Y, 2013. Three Leishmania/L. species–L. infantum, L. major, L. tropica–as causative agents of mucosal leishmaniasis in Iran. Pathog Glob Health 107: 267–272.
Kharfi M, Fazaa B, Chaker E, Kamoun MR, 2003. Mucosal localization of leishmaniasis in Tunisia: 5 cases [in French]. Ann Dermatol Venereol 130: 27–30.
Alborzi A, Pouladfar GR, Ghadimi Moghadam A, Attar A, Drakhshan N, Khosravi Maharlooei M, Kalantari M, 2013. First molecular-based detection of mucocutaneous leishmaniasis caused by Leishmania major in Iran. J Infect Dev Ctries 7: 413–416.
el Tai NO, Osman OF, el Fari M, Presber W, Schonian G, 2000. Genetic heterogeneity of ribosomal internal transcribed spacer in clinical samples of Leishmania donovani spotted on filter paper as revealed by single-strand conformation polymorphisms and sequencing. Trans R Soc Trop Med Hyg 94: 575–579.
van Griensven J, Carrillo E, Lopez-Velez R, Lynen L, Moreno J, 2014. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect 20: 286–299.
Tuon FF, Sabbaga Amato V, Floeter-Winter LM, de Andrade Zampieri R, Amato Neto V, Siqueira Franca FO, Shikanai-Yasuda MA, 2007. Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids: first report. Int J Dermatol 46: 628–630.
Motta AC, Arruda D, Souza CS, Foss NT, 2003. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid. Int J Dermatol 42: 703–706.
Blum J, Buffet P, Visser L, Harms G, Bailey MS, Caumes E, Clerinx J, van Thiel PP, Morizot G, Hatz C, Dorlo TP, Lockwood DN, 2014. LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014. J Travel Med 21: 116–129.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 553 | 447 | 78 |
Full Text Views | 369 | 11 | 0 |
PDF Downloads | 119 | 12 | 0 |
This report describes a case of mucosal leishmaniasis caused by Leishmania major with destructive perforation of the nasal septum illustrating the diagnostic challenges of a rare clinical presentation of L. major infection in a traveler. The atypical presentation may have been associated with the use of cortisone as a potential trigger for the progressive destruction of the nasal septum.
Consent for publication: The patient has provided written informed consent for publication of this case report.
Authors' addresses: Nicole Harrison, Luzia Veletzky, and Heimo Lagler, Division of Infectious Diseases and Tropical Medicine Department of Medicine I, Medical University of Vienna, Vienna, Austria, E-mails: nicole.harrison@meduniwien.ac.at, n1042220@students.meduniwien.ac.at, and heimo.lagler@meduniwien.ac.at. Julia Walochnik, Institute for Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria, E-mail: julia.walochnik@meduniwien.ac.at, Reinhard Ramsebner, Department for Otorhinolaryngology-Head and Neck Surgery, Medical University of Vienna, Vienna, Austria, E-mail: reinhard.ramsebner@meduniwien.ac.at. Michael Ramharter, Division of Infectious Diseases and Tropical Medicine Department of Medicine I, Medical University of Vienna, Vienna, Austria, and Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany, E-mail: michael.ramharter@meduniwien.ac.at.
Strazzulla A, Cocuzza S, Pinzone MR, Postorino MC, Cosentino S, Serra A, Cacopardo B, Nunnari G, 2013. Mucosal leishmaniasis: an underestimated presentation of a neglected disease. BioMed Res Int 2013: 805108.
Daulatabad D, Singal A, Dhawan A, Pandhi D, Sharma S, 2015. Mucocutaneous leishmaniasis caused by Leishmania donovani infection in an Indian man. Int J Dermatol 54: 680–684.
Aliaga L, Cobo F, Mediavilla JD, Bravo J, Osuna A, Amador JM, Martin-Sanchez J, Cordero E, Navarro JM, 2003. Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients. Medicine (Baltimore) 82: 147–158.
Shirian S, Oryan A, Hatam GR, Daneshbod Y, 2012. Mixed mucosal leishmaniasis infection caused by Leishmania tropica and Leishmania major. J Clin Microbiol 50: 3805–3808.
Shirian S, Oryan A, Hatam GR, Daneshbod Y, 2013. Three Leishmania/L. species–L. infantum, L. major, L. tropica–as causative agents of mucosal leishmaniasis in Iran. Pathog Glob Health 107: 267–272.
Kharfi M, Fazaa B, Chaker E, Kamoun MR, 2003. Mucosal localization of leishmaniasis in Tunisia: 5 cases [in French]. Ann Dermatol Venereol 130: 27–30.
Alborzi A, Pouladfar GR, Ghadimi Moghadam A, Attar A, Drakhshan N, Khosravi Maharlooei M, Kalantari M, 2013. First molecular-based detection of mucocutaneous leishmaniasis caused by Leishmania major in Iran. J Infect Dev Ctries 7: 413–416.
el Tai NO, Osman OF, el Fari M, Presber W, Schonian G, 2000. Genetic heterogeneity of ribosomal internal transcribed spacer in clinical samples of Leishmania donovani spotted on filter paper as revealed by single-strand conformation polymorphisms and sequencing. Trans R Soc Trop Med Hyg 94: 575–579.
van Griensven J, Carrillo E, Lopez-Velez R, Lynen L, Moreno J, 2014. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect 20: 286–299.
Tuon FF, Sabbaga Amato V, Floeter-Winter LM, de Andrade Zampieri R, Amato Neto V, Siqueira Franca FO, Shikanai-Yasuda MA, 2007. Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids: first report. Int J Dermatol 46: 628–630.
Motta AC, Arruda D, Souza CS, Foss NT, 2003. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid. Int J Dermatol 42: 703–706.
Blum J, Buffet P, Visser L, Harms G, Bailey MS, Caumes E, Clerinx J, van Thiel PP, Morizot G, Hatz C, Dorlo TP, Lockwood DN, 2014. LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014. J Travel Med 21: 116–129.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 553 | 447 | 78 |
Full Text Views | 369 | 11 | 0 |
PDF Downloads | 119 | 12 | 0 |